GoldCoin Health Foods Limited (BOM:538542)
India · Delayed Price · Currency is INR 31.79
+0.09 (0.28%)
At close: Aug 21, 2026
GoldCoin Health Foods Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 0.9 | 0.91 | 0.65 | 0.35 | 0.41 | 0.7 | |
Revenue Growth | 26.87% | 39.39% | 84.30% | -13.61% | -41.59% | -55.43% |
Cost of Revenue | 0.77 | 0.78 | 0.55 | 0.3 | 0.36 | 0.61 |
Gross Profit | 0.13 | 0.13 | 0.1 | 0.05 | 0.05 | 0.09 |
Selling, General & Admin | 0.97 | 0.97 | 1.01 | 0.95 | 0.11 | 0.15 |
Other Operating Expenses | 1.25 | 1.11 | 0.49 | 2.13 | 10.26 | 8.46 |
Operating Expenses | 2.22 | 2.08 | 1.5 | 3.27 | 10.57 | 11.28 |
Operating Income | -2.1 | -1.95 | -1.4 | -3.22 | -10.52 | -11.18 |
Interest Expense | -0.1 | -0.08 | -0.04 | -0.06 | -0.06 | -0.03 |
Interest & Investment Income | - | - | 0.22 | 0.1 | 0.2 | 0.29 |
Other Non Operating Income (Expenses) | 0.35 | 1.58 | -0 | -0 | -0 | -0 |
EBT Excluding Unusual Items | -1.85 | -0.45 | -1.22 | -3.18 | -10.38 | -10.93 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.1 |
Pretax Income | -1.85 | -0.45 | -1.22 | -3.18 | -10.38 | -11.04 |
Income Tax Expense | -0.16 | - | - | 0.03 | - | - |
Net Income | -1.69 | -0.45 | -1.22 | -3.21 | -10.38 | -11.04 |
Net Income to Common | -1.69 | -0.45 | -1.22 | -3.21 | -10.38 | -11.04 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 1 | 2 | 2 | 2 | 2 | 2 |
Shares Change | -20.06% | 0.41% | - | - | - | - |
EPS (Basic) | -1.46 | -0.30 | -0.81 | -2.14 | -6.92 | -7.35 |
EPS (Diluted) | -1.46 | -0.30 | -0.82 | -2.14 | -6.92 | -7.36 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -6.8 | 3.99 | -2.16 | -14.95 | -8.97 |
Free Cash Flow Per Share | - | -4.51 | 2.66 | -1.44 | -9.96 | -5.98 |
Gross Margin | 14.38% | 14.33% | 15.15% | 14.75% | 12.80% | 13.43% |
Operating Margin | -233.56% | -215.11% | -215.66% | -911.64% | -2573.82% | -1598.36% |
Profit Margin | -187.96% | -49.84% | -187.63% | -909.51% | -2539.71% | -1577.25% |
Free Cash Flow Margin | - | -749.39% | 613.55% | -611.33% | -3657.46% | -1282.74% |
EBITDA | -2.09 | -1.95 | -1.4 | -3.02 | -10.32 | -10.98 |
EBITDA Margin | -232.88% | -214.44% | -214.78% | - | - | - |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.2 | 0.2 | 0.2 |
EBIT | -2.1 | -1.95 | -1.4 | -3.22 | -10.52 | -11.18 |
EBIT Margin | -233.56% | -215.11% | -215.66% | - | - | - |
Revenue as Reported | 1.25 | 2.49 | 0.87 | 0.45 | 0.61 | 0.99 |